Baker Bros. Advisors’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Baker Bros. Advisors’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-499,193	Closed	-$2.45M	–	136
2016 Q4	$2.45M	Hold	499,193	–	–	0.02%	87
2016 Q3	$2.48M	Hold	499,193	–	–	0.02%	89
2016 Q2	$2.54M	Hold	499,193	–	–	0.03%	89
2016 Q1	$2.85M	Hold	499,193	–	–	0.03%	88
2015 Q4	$5.18M	Hold	499,193	–	–	0.04%	77
2015 Q3	$9.22M	Hold	499,193	–	–	0.09%	65
2015 Q2	$9.71M	Hold	499,193	–	–	0.09%	64
2015 Q1	$8.78M	Sell	499,193 -11,413	-2%	-$192K	0.07%	62
2014 Q4	$8.16M	Hold	510,606	–	–	0.08%	54
2014 Q3	$6.43M	Hold	510,606	–	–	0.08%	55
2014 Q2	$7.98M	Buy	510,606 +149,076	+41%	+$2.19M	0.1%	50
2014 Q1	$4.75M	Sell	361,530 -13,752	-4%	-$215K	0.06%	73
2013 Q4	$6.04M	Hold	375,282	–	–	0.09%	58
2013 Q3	$6.25M	Buy	+375,282	New	+$5.55M	0.09%	51

Other funds holding OSIR

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Baker Bros. Advisors's OSIR Position: Q1 2017 in Review

Baker Bros. Advisors sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2017, closing a stake of 499,193 shares — an estimated $2.45M sold.

Baker Bros. Advisors first reported a position in OSIR in Q3 2013 and held it in 14 quarters. The position peaked at $9.71M in Q2 2015. 11 funds tracked by Wall St. Rank hold OSIR as of Q1 2017.

Baker Bros. Advisors reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
Baker Bros. Advisors sold 499,193 Osiris Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $2.45M.
Baker Bros. Advisors first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2013 and held it in 14 quarters.
Baker Bros. Advisors's Osiris Therapeutics, Inc. Common Stock position peaked at $9.71M in Q2 2015.
11 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2017.

Based on Baker Bros. Advisors's 13F filing for Q1 2017, filed 15 May 2017.